Spironolactone for the Prevention of Microalbuminuria in High-Risk Type 2 Diabetes: Results from the Multicenter Randomized Double-Blind Controlled Trial PRIORITY

Research output: Contribution to journalConference abstract in journalResearchpeer-review

  • Morten Lindhardt
  • Nete Tofte
  • Marie Frimodt-Møller
  • Gemma Currie
  • Christian Delles
  • Heiko von der Leyen
  • Harald Mischak
  • Rossing, Peter
Original languageEnglish
Article numberFR-PO247
JournalJournal of the American Society of Nephrology
Volume30
Issue numberKidney Week Edition
Number of pages1
ISSN1046-6673
Publication statusPublished - 2019

ID: 239210971